Your browser doesn't support javascript.
loading
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
Chang, Chun-Mien; Awanye, Amaka M; Marsay, Leanne; Dold, Christina; Pollard, Andrew J; Rollier, Christine S; Feavers, Ian M; Maiden, Martin C J; Derrick, Jeremy P.
Afiliação
  • Chang CM; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
  • Awanye AM; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK.
  • Marsay L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; School of Biosciences and Medicine, University of Surrey, Guildford, UK.
  • Feavers IM; National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, UK; Department of Zoology, University of Oxford, 11a Mansfield Road, Oxford OX1 3SZ, UK.
  • Maiden MCJ; Department of Zoology, University of Oxford, 11a Mansfield Road, Oxford OX1 3SZ, UK.
  • Derrick JP; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PL, UK. Electronic address: Jeremy.Derrick@manchester.ac.uk.
Vaccine ; 40(28): 3835-3842, 2022 06 21.
Article em En | MEDLINE | ID: mdl-35610106
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo B / Infecções Meningocócicas / Neisseria meningitidis Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo B / Infecções Meningocócicas / Neisseria meningitidis Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article